Themis Medicare Limited — Board Meeting, 18-11-2024: Outcome of Board Meeting

The Board of Themis Medicare Limited has reviewed restructuring options aimed at business consolidation for sustainable growth. Key resolutions include terminating the agreement to transfer the Active Pharmaceutical Ingredients business to Themis Lifestyle Pvt. Ltd. and approving a draft Scheme of Amalgamation with Gujarat Themis Biosyn Limited. As of September 30, 2024, Gujarat Themis Biosyn reported total assets of ₹248.15 Cr, net worth of ₹223.42 Cr, and a turnover of ₹74.39 Cr. Themis Medicare's total assets were ₹515.36 Cr, with a net worth of ₹292.05 Cr and a turnover of ₹207.15 Cr for the same period. The scheme awaits necessary approvals from regulatory authorities.